旧问题,新解决方案:在帕金森病中利用技术和创新-泰国的证据和经验
1Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, 1873 Rama 4 Road, Bangkok, 10330, Thailand. rbh@chulapd.org.
Journal of neural transmission (Vienna, Austria : 1996)
|January 8, 2024
概括
在低资源环境中,帕金森病 (PD) 护理面临着挑战. 泰国 泰国 泰国 泰国
科学领域:
- 神经学 神经学
- 全球健康 全球健康
背景情况:
- 帕金森病 (PD) 患病率在全球上升,不成比例地影响低收入和中等收入国家 (LMICs).
- 在全球PD医疗资源分配中存在显著的不平等.
- 泰国是LMIC面临相当大的PD负担和资源限制的例子.
研究的目的:
- 描述泰国帕金森病医疗保健的演变,作为LMICs的案例研究.
- 审查泰国为PD护理实施的挑战和创新解决方案.
- 突出技术和生活方式干预措施在管理PD大流行中的作用.
主要方法:
- 泰国PD医疗保健演变的案例研究分析.
- 审查实施的技术创新和医疗保健专业人员培训.
- 检查预防性生活方式策略来降低PD风险.
主要成果:
- 泰国已经实施了新的解决方案,以提高医疗保健专业人员的技能,并改善PD护理服务.
- 技术和创新对于应对PD管理的区域挑战至关重要.
- 由于缺乏治愈疗法,重点转向预防性生活方式策略 (营养,运动,睡眠,环境保护).
结论:
- 在LMICs中有效的PD护理需要通过创新的解决方案和技术来应对区域挑战.
- 预防性生活方式策略对于缓解日益增长的PD流行病至关重要.
- 泰国的经验为改善全球PD医疗保健公平提供了有价值的见解.
相关概念视频
01:24Parkinson's Disease: Treatment
272
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
272
01:15Parkinson's Disease: Overview
551
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
551